A new drug made from cannabis has been licensed in the UK. Sativex, a tincture of extracts from the plant, is sprayed under the tongue up to 12 times a day, as a treatment for the stiffness and spasticity associated with multiple sclerosis. The Home Office has rated it as having zero abuse potential. Britain is the first country to give the drug full regulatory approval, although Canada gave Sativex a limited license to treat neuropathic pain in 2005. It is made from plants grown at a secret location in southern England by GW Pharmaceuticals, whose shares have risen 60% in the last six months in anticipation of the new product.
Recent comments
18 weeks 4 days ago
33 weeks 3 days ago
41 weeks 6 days ago
41 weeks 6 days ago
43 weeks 1 day ago
47 weeks 4 days ago
48 weeks 5 days ago
50 weeks 1 day ago
1 year 3 days ago
1 year 4 weeks ago